| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal brain function in photophobic patients with dry eye disease: An fMRI study
|
Tazi, S.
|
|
|
|
6 |
p. 599-606
|
artikel
|
| 2 |
Acute meningoencephalitis in a patient with COVID-19
|
Chaumont, H.
|
|
|
|
6 |
p. 519-521
|
artikel
|
| 3 |
Acute relapsing ataxic sensory neuronopathy with anti-FGFR3 autoantibodies mimicking acute myelopathy
|
Theuriet, J.
|
|
|
|
6 |
p. 626-627
|
artikel
|
| 4 |
A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study
|
Gauer, L.
|
|
|
|
6 |
p. 576-584
|
artikel
|
| 5 |
An unusual case of acute myelopathy: Surfer's myelopathy in a teenage gymnast
|
Bouattour, N.
|
|
|
|
6 |
p. 717-719
|
artikel
|
| 6 |
A regional strategy to decrease the time to thrombectomy in patients with low probability of treatment by thrombolysis
|
Ter Schiphorst, A.
|
|
|
|
6 |
p. 558-568
|
artikel
|
| 7 |
Are the results of intravenous thrombolysis trials reproduced in clinical practice? Comparison of observed and expected outcomes with the stroke-thrombolytic predictive instrument (STPI)
|
Decourcelle, A.
|
|
2017
|
|
6 |
p. 381-387
7 p.
|
artikel
|
| 8 |
Artificial intelligence and ChatGPT between worst enemy and best friend: The two faces of a revolution and its impact on science and medical schools
|
Aubignat, M.
|
|
|
|
6 |
p. 520-522
|
artikel
|
| 9 |
Asymptomatic stroke is an underestimated side effect of cabozantinib
|
Bronnimann, C.
|
|
|
|
6 |
p. 409-410
|
artikel
|
| 10 |
Atypical inflammatory demyelinating lesions and atypical multiple sclerosis
|
Ayrignac, X.
|
|
2018
|
|
6 |
p. 408-418
|
artikel
|
| 11 |
BRAF mutation in overlapping form of Erdheim-Chester and Rosai Dorfman diseases: a unique case restricted to the central nervous system
|
Dufour, J.
|
|
|
|
6 |
p. 708-710
|
artikel
|
| 12 |
Carotid webs associated with ischemic stroke. Updated general review and research directions
|
Olindo, S.
|
|
|
|
6 |
p. 627-638
|
artikel
|
| 13 |
Cerebral lymphoma presenting as a rhombencephalitis: Case report and review of the literature
|
Herrscher, H.
|
|
|
|
6 |
p. 412-414
|
artikel
|
| 14 |
Cerebral venous thrombosis in a sub-saharan African country: A preliminary monocentric study of a 70 case series at the neurology department of Fann teaching hospital in Dakar – Senegal
|
Gaye, N.M.
|
|
|
|
6 |
p. 670-675
|
artikel
|
| 15 |
Challenges in diagnosis of motor neuron disease: A case series of ALS mimic syndromes
|
Barp, A.
|
|
|
|
6 |
p. 699-706
|
artikel
|
| 16 |
Classification and diagnostic criteria for demyelinating diseases of the central nervous system: Where do we stand today?
|
Mathey, G.
|
|
2018
|
|
6 |
p. 378-390
|
artikel
|
| 17 |
Comparison of magnetic resonance angiography techniques to brain digital subtraction arteriography in the setting of mechanical thrombectomy: A non-inferiority study
|
Bani-Sadr, A.
|
|
|
|
6 |
p. 539-545
|
artikel
|
| 18 |
Complex hallucinations induced by lamotrigine
|
El Otmani, H.
|
|
|
|
6 |
p. 410-411
|
artikel
|
| 19 |
Congenital myasthenic syndrome by mutation of the ColQ gene: Phenotypic and evolutionary profile of three Algerian families
|
Kediha, M.I.
|
|
|
|
6 |
p. 570-575
|
artikel
|
| 20 |
Connected health and multiple sclerosis
|
Cohen, M.
|
|
2018
|
|
6 |
p. 480-485
|
artikel
|
| 21 |
Contents
|
|
|
|
|
6 |
p. iv-v
|
artikel
|
| 22 |
Contents
|
|
|
|
|
6 |
p. iii-iv
|
artikel
|
| 23 |
Conventional and advanced MRI in multiple sclerosis
|
Louapre, C.
|
|
2018
|
|
6 |
p. 391-397
|
artikel
|
| 24 |
Corrigendum to « Low back pain in patients with Multiple Sclerosis : A systematic review and the prevalence in a French Multiple Sclerosis population» [Revue neurologique. Volume 177, Issue 4, (April 2021), Pages 349-358]
|
Massot, C.
|
|
|
|
6 |
p. 722
|
artikel
|
| 25 |
Corrigendum to “Measles Sclerosing Subacute PanEncephalitis (SSPE), an intriguing and ever-present disease: Data, Assumptions and new Perspectives” [Rev. Neurol. 177 (2021) 1059–68]
|
Lebon, P.
|
|
|
|
6 |
p. 634
|
artikel
|
| 26 |
Covid-19 and Guillain-Barré syndrome: More than a coincidence!
|
El Otmani, H.
|
|
|
|
6 |
p. 518-519
|
artikel
|
| 27 |
COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
|
Aubignat, M.
|
|
|
|
6 |
p. 505-506
|
artikel
|
| 28 |
COVID-19 may induce Guillain–Barré syndrome
|
Camdessanche, J.-P.
|
|
|
|
6 |
p. 516-518
|
artikel
|
| 29 |
Demyelinating diseases
|
Lebrun, C.
|
|
2018
|
|
6 |
p. 355
|
artikel
|
| 30 |
Depression could modulate neuropsychological status in epilepsy
|
Forthoffer, N.
|
|
|
|
6 |
p. 456-467
|
artikel
|
| 31 |
Descriptive study of the parkinsonian population in the north of France: Epidemiological analysis and healthcare consumption
|
Carriere, N.
|
|
2017
|
|
6 |
p. 396-405
10 p.
|
artikel
|
| 32 |
Detection of adult attention deficit hyperactivity disorder with cognitive complaint: Experience of a French memory center
|
Pierre, M.
|
|
|
|
6 |
p. 358-366
|
artikel
|
| 33 |
Development and initial validation of the polyhandicap severity scale
|
Rousseau, M.-C.
|
|
|
|
6 |
p. 683-689
|
artikel
|
| 34 |
Diaphragm ultrasound in the diagnosis of respiratory dysfunction in patients with amyotrophic lateral sclerosis
|
Wen, Q.
|
|
|
|
6 |
p. 639-646
|
artikel
|
| 35 |
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment
|
Ouallet, J.-C.
|
|
|
|
6 |
p. 500-504
|
artikel
|
| 36 |
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? No
|
Labauge, P.
|
|
|
|
6 |
p. 494-496
|
artikel
|
| 37 |
Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Yes
|
de Seze, J.
|
|
|
|
6 |
p. 497-499
|
artikel
|
| 38 |
Does post dural puncture headache exist in idiopathic intracranial hypertension? A pilot study
|
Didier-Laurent, A.
|
|
|
|
6 |
p. 676-682
|
artikel
|
| 39 |
Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?
|
Kreisler, A.
|
|
|
|
6 |
p. 591-602
|
artikel
|
| 40 |
Do we know how to diagnose epilepsy early in Alzheimer's disease?
|
Cretin, B.
|
|
2017
|
|
6 |
p. 374-380
7 p.
|
artikel
|
| 41 |
Dyskinesia and hyperpyrexia syndrome: A case report and review of the literature
|
Zu, J.
|
|
|
|
6 |
p. 710-713
|
artikel
|
| 42 |
Early lesion reversal on DWI and FLAIR after thrombectomy reperfusion in acute ischemic stroke
|
Gory, B.
|
|
2017
|
|
6 |
p. 422-424
3 p.
|
artikel
|
| 43 |
Editorial
|
Thouvenot, É.
|
|
|
|
6 |
p. 339-340
|
artikel
|
| 44 |
Editorial Board
|
|
|
2017
|
|
6 |
p. i-
1 p.
|
artikel
|
| 45 |
Editorial Board
|
|
|
|
|
6 |
p. i
|
artikel
|
| 46 |
Editorial Board
|
|
|
2018
|
|
6 |
p. i
|
artikel
|
| 47 |
Editorial Board
|
|
|
|
|
6 |
p. i
|
artikel
|
| 48 |
Editorial Board
|
|
|
|
|
6 |
p. i
|
artikel
|
| 49 |
Editorial Board
|
|
|
|
|
6 |
p. i
|
artikel
|
| 50 |
Editorial Board
|
|
|
|
|
6 |
p. i
|
artikel
|
| 51 |
Environmental factors in the development of multiple sclerosis
|
Michel, L.
|
|
2018
|
|
6 |
p. 372-377
|
artikel
|
| 52 |
Erratum to “What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? A review of literature” [Rev. Neurol. 176 (4) (2019) 235–243]
|
Pourcher, V.
|
|
|
|
6 |
p. 526
|
artikel
|
| 53 |
Estimated number of eligible patients for mechanical thrombectomy based on NIHSS and population-based Brest stroke registry
|
Simoni-Bazziconi, L.
|
|
|
|
6 |
p. 546-557
|
artikel
|
| 54 |
Etiological assessment of status epilepticus
|
Valton, L.
|
|
|
|
6 |
p. 408-426
|
artikel
|
| 55 |
Evaluation of miR-526b-3p, miR-1179, miR-3529-3p, miR-5011-5p as potential diagnostic biomarkers in isolated cervical dystonia
|
Gelisin, O.
|
|
|
|
6 |
p. 563-569
|
artikel
|
| 56 |
Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients
|
Veillard, D.
|
|
|
|
6 |
p. 580-590
|
artikel
|
| 57 |
Evidence of presynaptic dopaminergic dysfunction in acute methanol intoxication
|
Doé de Maindreville, A.
|
|
2017
|
|
6 |
p. 420-422
3 p.
|
artikel
|
| 58 |
Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients
|
Bouchikh, M.
|
|
2017
|
|
6 |
p. 388-395
8 p.
|
artikel
|
| 59 |
First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case
|
Hemasian, H.
|
|
|
|
6 |
p. 521-523
|
artikel
|
| 60 |
First-line therapy in relapsing remitting multiple sclerosis
|
Biotti, D.
|
|
2018
|
|
6 |
p. 419-428
|
artikel
|
| 61 |
FOXP3 rs3761548 gene variant and interleukin-35 serum levels as biomarkers in patients with multiple sclerosis
|
Kamal, A.
|
|
|
|
6 |
p. 647-654
|
artikel
|
| 62 |
From hysteria to gait dementia: History of the concept of astasia-abasia
|
Walusinski, O.
|
|
|
|
6 |
p. 523-532
|
artikel
|
| 63 |
Genetic/idiopathic generalized epilepsies: Not so good as that!
|
Nilo, A.
|
|
|
|
6 |
p. 427-438
|
artikel
|
| 64 |
Genetics and familial distribution of multiple sclerosis: A review
|
Balcerac, A.
|
|
|
|
6 |
p. 512-520
|
artikel
|
| 65 |
Getting older with chronic temporal lobe epilepsy: What memory profile?
|
Samson, S.
|
|
|
|
6 |
p. 439-443
|
artikel
|
| 66 |
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network
|
Solé, G.
|
|
|
|
6 |
p. 507-515
|
artikel
|
| 67 |
Health care transition for cerebral palsy with intellectual disabilities: A systematic review
|
Osako, M.
|
|
|
|
6 |
p. 585-598
|
artikel
|
| 68 |
Health policy for telestroke in France: A retrospective description from 2003 to 2016
|
Ohannessian, R.
|
|
|
|
6 |
p. 390-395
|
artikel
|
| 69 |
Henry Meige: The man and his understanding of dystonia, at the turn of the 19th to 20th century
|
Marion, M.-H.
|
|
|
|
6 |
p. 532-538
|
artikel
|
| 70 |
High risk of osteoporotic fracture in Parkinson's disease: Meta-analysis, pathophysiology and management
|
Louvois, M.
|
|
|
|
6 |
p. 660-669
|
artikel
|
| 71 |
Horner syndrome as the sole manifestation of an ipsilateral intrapetrous internal carotid artery dissection
|
Hebant, B.
|
|
|
|
6 |
p. 719-721
|
artikel
|
| 72 |
How much progress has there been in the second-line treatment of multiple sclerosis: A 2017 update
|
Maarouf, A.
|
|
2018
|
|
6 |
p. 429-440
|
artikel
|
| 73 |
Immune-mediated necrotizing myopathy following vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine: A case report and brief review
|
Ansari, B.
|
|
|
|
6 |
p. 630-635
|
artikel
|
| 74 |
Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society
|
Lebrun, C.
|
|
|
|
6 |
p. 341-357
|
artikel
|
| 75 |
Immunoglobulin shortage: Practice modifications and clinical outcomes in a reference centre
|
N’kaoua, E.
|
|
|
|
6 |
p. 616-623
|
artikel
|
| 76 |
Impact of astrocyte and lymphocyte interactions on the blood-brain barrier in multiple sclerosis
|
Yan, X.-B.
|
|
|
|
6 |
p. 396-402
|
artikel
|
| 77 |
Impaired decision-making and time perception in individuals with stroke: Behavioral and neural correlates
|
Marinho, V.
|
|
|
|
6 |
p. 367-376
|
artikel
|
| 78 |
Induction or escalation therapy for patients with multiple sclerosis?
|
Le Page, E.
|
|
2018
|
|
6 |
p. 449-457
|
artikel
|
| 79 |
Intracerebral hemorrhage revealing eosinophilic granulomatosis with polyangiitis (EGPA): A case report
|
Frikha, F.
|
|
|
|
6 |
p. 631-633
|
artikel
|
| 80 |
Intravenous thrombolysis and thrombectomy decisions in acute ischemic stroke: An interrater and intrarater agreement study
|
Ducroux, C.
|
|
|
|
6 |
p. 380-389
|
artikel
|
| 81 |
Jules Tinel (1879–1952): Beyond the eponym, the man and his forgotten neurological contributions
|
Walusinski, O.
|
|
2017
|
|
6 |
p. 364-373
10 p.
|
artikel
|
| 82 |
Left hemi-conus medullaris hematomyelia complicating oral anticoagulant therapy
|
Boukobza, M.
|
|
|
|
6 |
p. 629-631
|
artikel
|
| 83 |
Lennox-Gastaut syndrome: New treatments and treatments under investigation
|
Auvin, S.
|
|
|
|
6 |
p. 444-447
|
artikel
|
| 84 |
‘Le tic’: A short story on psychogenic tics by Guy de Maupassant
|
Cavanna, A.E.
|
|
|
|
6 |
p. 628-629
|
artikel
|
| 85 |
Long-term cognitive outcomes in patient with epilepsy
|
Forthoffer, N.
|
|
|
|
6 |
p. 448-455
|
artikel
|
| 86 |
Louis Tanquerel des Planches (1810-1862) and the history of discovering lead poisoning in the nervous system
|
Walusinski, O.
|
|
|
|
6 |
p. 521-531
|
artikel
|
| 87 |
Major depressive disorder masking frontotemporal dementia secondary to C9orf72 mutation: A case report
|
Tastevin, M.
|
|
|
|
6 |
p. 405-407
|
artikel
|
| 88 |
Management and outcome of cerebral venous thrombosis after head trauma: A case series
|
Grangeon, L.
|
|
2017
|
|
6 |
p. 411-417
7 p.
|
artikel
|
| 89 |
Miller Fisher syndrome mimicking botulism: Clinical and pathophysiological discussion of a case
|
Bigaut, K.
|
|
|
|
6 |
p. 403-405
|
artikel
|
| 90 |
Multiple sclerosis biomarkers: Helping the diagnosis?
|
Thouvenot, E.
|
|
2018
|
|
6 |
p. 364-371
|
artikel
|
| 91 |
Multiple Sclerosis over the last 25 years: an introduction
|
Edan, G.
|
|
2018
|
|
6 |
p. 353-354
|
artikel
|
| 92 |
Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination
|
Bellakhdar, S.
|
|
|
|
6 |
p. 624-625
|
artikel
|
| 93 |
Neuro-ChatGPT? Potential threats and certain opportunities
|
Moisset, X.
|
|
|
|
6 |
p. 517-519
|
artikel
|
| 94 |
Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes
|
Alves Do Rego, C.
|
|
2018
|
|
6 |
p. 458-470
|
artikel
|
| 95 |
New insights for predicting surgery outcome in patients with temporal lobe epilepsy. A systematic review
|
Baciu, M.
|
|
|
|
6 |
p. 607-629
|
artikel
|
| 96 |
New-onset extrapyramidal symptoms in hepatic cirrhosis without neuroimaging signs of encephalopathy
|
Chirchiglia, D.
|
|
|
|
6 |
p. 407-409
|
artikel
|
| 97 |
Non-infectious meningitis and CNS demyelinating diseases: A conceptual review
|
Etemadifar, M.
|
|
|
|
6 |
p. 533-547
|
artikel
|
| 98 |
Organization of care for multiple sclerosis in France
|
Derache, N.
|
|
2018
|
|
6 |
p. 475-479
|
artikel
|
| 99 |
Organization of healthcare in multiple sclerosis
|
Gignoux, L.
|
|
2018
|
|
6 |
p. 471-474
|
artikel
|
| 100 |
Othello syndrome in Parkinson's disease: A diagnostic emergency of an underestimated condition
|
El Otmani, H.
|
|
|
|
6 |
p. 690-693
|
artikel
|
| 101 |
Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment
|
Dufournet, B.
|
|
2017
|
|
6 |
p. 406-410
5 p.
|
artikel
|
| 102 |
Paroxysmal dyskinesia: When a PRRT2 variant hides a curable cause
|
Schneider, V.
|
|
|
|
6 |
p. 707-708
|
artikel
|
| 103 |
Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
|
Louapre, C.
|
|
|
|
6 |
p. 523-525
|
artikel
|
| 104 |
Peduncular hallucinosis according to Jean Lhermitte
|
Drouin, E.
|
|
|
|
6 |
p. 377-379
|
artikel
|
| 105 |
Perception of seizure severity and bothersome in refractory focal epilepsy
|
Tedrus, G.M.A.S.
|
|
|
|
6 |
p. 603-608
|
artikel
|
| 106 |
Postictal pure retrograde amnesia
|
Vercueil, L.
|
|
2017
|
|
6 |
p. 426-427
2 p.
|
artikel
|
| 107 |
Post-infectious relapsing encephalomyelitis due to toxocara canis
|
Legris, L.
|
|
|
|
6 |
p. 713-715
|
artikel
|
| 108 |
Predictive factors of postoperative outcome in the elderly after resective epilepsy surgery
|
Thomas, B.
|
|
|
|
6 |
p. 609-615
|
artikel
|
| 109 |
Prevalence of spasticity and spasticity-related pain among patients with Amyotrophic Lateral Sclerosis
|
Verschueren, A.
|
|
|
|
6 |
p. 694-698
|
artikel
|
| 110 |
Prevalent tuberculoma of a disseminated tuberculosis mimicking brain metastasis
|
Guyot, B.
|
|
|
|
6 |
p. 715-717
|
artikel
|
| 111 |
Progress in understanding the pathophysiology of multiple sclerosis
|
Zéphir, H.
|
|
2018
|
|
6 |
p. 358-363
|
artikel
|
| 112 |
Retinal vessels as a window on amyotrophic lateral sclerosis pathophysiology: A systematic review
|
Vautier, A.
|
|
|
|
6 |
p. 548-562
|
artikel
|
| 113 |
Seizure incidence among neuromyelitis optica spectrum disorder patients
|
Etemadifar, M.
|
|
|
|
6 |
p. 655-659
|
artikel
|
| 114 |
Should spinal cord MRI be systematically performed for diagnosis and follow-up of multiple sclerosis? No
|
Kremer, S.
|
|
|
|
6 |
p. 485-486
|
artikel
|
| 115 |
Should spinal cord MRI be systematically performed for diagnosis and follow-up of multiple sclerosis? Synthesis
|
Durand-Dubief, F.
|
|
|
|
6 |
p. 490-493
|
artikel
|
| 116 |
Should spinal cord MRI be systematically performed for diagnosis and follow up of multiple sclerosis? Yes
|
Kerbrat, A.
|
|
|
|
6 |
p. 487-489
|
artikel
|
| 117 |
Social cognition in epilepsy: State of the art and perspectives
|
Mirabel, H.
|
|
|
|
6 |
p. 468-479
|
artikel
|
| 118 |
Subacute monomelic radiculoplexus neuropathy following Comirnaty© (Pfizer-BioNTech COVID-19) vaccination: A case report
|
Coly, M.
|
|
|
|
6 |
p. 636-639
|
artikel
|
| 119 |
Symptomatic cervical myelopathy due to general dystonia: Case report and review of the literature
|
Gilard, V.
|
|
2017
|
|
6 |
p. 424-426
3 p.
|
artikel
|
| 120 |
Ten-year follow-up after mitoxantrone induction for early highly active relapsing-remitting multiple sclerosis: An observational study of 100 consecutive patients
|
Lefort, M.
|
|
|
|
6 |
p. 569-579
|
artikel
|
| 121 |
The COVID-19 pandemic, an environmental neurology perspective
|
Reis, J.
|
|
|
|
6 |
p. 499-511
|
artikel
|
| 122 |
The future of ALS might move towards Genetic Therapy
|
Corcia, P.
|
|
|
|
6 |
p. 613-614
|
artikel
|
| 123 |
The future of epilepsy
|
Dupont, S.
|
|
|
|
6 |
p. 407
|
artikel
|
| 124 |
The veiled intimacy between neurology and Vincent van Gogh
|
Kusznir Vitturi, B.
|
|
|
|
6 |
p. 615-618
|
artikel
|
| 125 |
Topiramate response in adult-onset opsoclonus–myoclonus–ataxia syndrome: A case report
|
Degirmenci, Y.
|
|
2017
|
|
6 |
p. 418-420
3 p.
|
artikel
|
| 126 |
Treatment of progressive multiple sclerosis: Challenges and promising perspectives
|
Maillart, E.
|
|
2018
|
|
6 |
p. 441-448
|
artikel
|
| 127 |
Update on pediatric-onset multiple sclerosis
|
Ruet, A.
|
|
2018
|
|
6 |
p. 398-407
|
artikel
|
| 128 |
Visual and motor neglect: Clinical and neurocognitive aspects
|
Bartolomeo, P.
|
|
|
|
6 |
p. 619-626
|
artikel
|
| 129 |
Wearable devices for seizure detection: Is it time to translate into our clinical practice?
|
Rheims, S.
|
|
|
|
6 |
p. 480-484
|
artikel
|
| 130 |
Zika virus and Guillain–Barré syndrome
|
Dub, T.
|
|
2017
|
|
6 |
p. 361-363
3 p.
|
artikel
|
Tijdschrift beschrijving